The serum LH level in each group was lower than that of FSH, and there was no difference in serum testosterone levels, suggesting that the endocrine status of clomiphene-resistance PCOS patients was normal and suitable for ovulation induction therapy. This evidence concerns the gene BRD2 and polycystic ovary syndrome.